These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 2239590

  • 1. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M, Ikegami M, Ishii T, Nishioka T, Uemura T, Kunikata S, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P, Akkasilpa S, Deesomchok U.
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W, Walter-Sack I, de Vries JX.
    Eur J Med Res; 1998 Feb 21; 3(1-2):77-80. PubMed ID: 9512972
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S, Osiri M, Deesomchok U, Avihingsanon Y.
    J Med Assoc Thai; 2004 Sep 21; 87(9):1087-91. PubMed ID: 15516011
    [Abstract] [Full Text] [Related]

  • 6. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan 21; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jan 21; 68(1):51-6. PubMed ID: 18250112
    [Abstract] [Full Text] [Related]

  • 8. [The treatment of hyperuricemia after kidney transplantation].
    Flury W, Ruch HR, Montandon A.
    Schweiz Med Wochenschr; 1977 Sep 24; 107(38):1339-41. PubMed ID: 335500
    [Abstract] [Full Text] [Related]

  • 9. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F, Neuwirth R, Berg G.
    Fortschr Med; 1976 Sep 16; 94(26):1427-9. PubMed ID: 976920
    [Abstract] [Full Text] [Related]

  • 10. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A.
    Arthritis Rheum; 2002 Aug 16; 47(4):356-60. PubMed ID: 12209479
    [Abstract] [Full Text] [Related]

  • 11. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N.
    Arthritis Rheum; 2008 Nov 15; 59(11):1540-8. PubMed ID: 18975369
    [Abstract] [Full Text] [Related]

  • 12. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 13. [The use of Allomaron in treating hyperuricemia].
    Balkarov IM.
    Ter Arkh; 1994 Nov 22; 66(1):40-2. PubMed ID: 8146793
    [No Abstract] [Full Text] [Related]

  • 14. Benzbromarone therapy in management of refractory gout.
    Kumar S, Ng J, Gow P.
    N Z Med J; 2005 Jun 24; 118(1217):U1528. PubMed ID: 15980902
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M, Hachicha J, Bahloul Z, Kaddour N, Kharrat M, Jarraya F, Jarraya A.
    Transplant Proc; 1995 Oct 24; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract] [Full Text] [Related]

  • 16. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S.
    Nihon Rinsho; 2008 Apr 24; 66(4):729-35. PubMed ID: 18409523
    [Abstract] [Full Text] [Related]

  • 17. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG, Miranda ME, Mateos FA, Picazo ML, Jiménez ML, Calvin TS, Gil AA.
    Arch Intern Med; 1993 Feb 08; 153(3):357-65. PubMed ID: 8427538
    [Abstract] [Full Text] [Related]

  • 18. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H.
    Z Gesamte Inn Med; 1990 Dec 01; 45(23):719-20. PubMed ID: 2102029
    [Abstract] [Full Text] [Related]

  • 19. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G, Arikan C, Kilic M, Aydogdu S.
    Pediatr Transplant; 2006 Sep 01; 10(6):665-8. PubMed ID: 16911488
    [Abstract] [Full Text] [Related]

  • 20. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP.
    Med Klin; 1977 Apr 15; 72(15):664-8. PubMed ID: 857138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.